GDF15 and metabolic dysfunction-associated steatotic liver disease: Importantly, GDF15 protein levels were also increased in hepatocytes of TPI-treated mice (Supplemental Figure 5G), suggesting that inhibition of TP induced ISRmt in hepatocytes, leading to the exacerbation of MASLD.